(Q45382330)

English

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.

scientific article published on 3 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

0 references

Joanne M. Langley

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Valerie Sales

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Roland Guasparini

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gerald Predy

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

William Meekison

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Minran Li

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jose Capellan

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Elaine Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

3 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5913-5919

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Risk factors for severe respiratory syncytial virus infection in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Respiratory syncytial virus infection in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Respiratory syncytial virus infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Severity of respiratory syncytial virus infection is related to virus strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.038

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.038

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45382330&oldid=1402063799"